Cooperative Research Centre

Gainwell Enables Breakthrough Southern Methodist University Research on Hospital Readmissions for Medicaid Diabetes Patients

Retrieved on: 
Tuesday, October 17, 2023
The American Journal of Managed Care, Health, Data science, Hospital, Southern Methodist University, Research, SMU, American Journal, Government, Kenneth Gainwell, Risk, AJMC, Diabetes, Statistics, Mortality, Methodist University, Medicare, Digital technology, Cooperative Research Centre, University, Digital health, Patient, Pharmaceutical industry, Health insurance, Medical device, Medicaid

Gainwell Technologies (Gainwell), a leading innovator in healthcare technology solutions, partnered with its state Medicaid clients and SMU (Southern Methodist University) to develop an answer.

Key Points: 
  • Gainwell Technologies (Gainwell), a leading innovator in healthcare technology solutions, partnered with its state Medicaid clients and SMU (Southern Methodist University) to develop an answer.
  • They are also twice as likely to be readmitted within 30 days of discharge as similar patients without diabetes.
  • Using claims data only, SMU concluded Medicaid patients with diabetes were much more likely to be readmitted to hospitals within 30 days of their release than Medicaid patients without diabetes.
  • Some of the most significant findings from the research were:
    Researchers derived and validated a Medicaid claims-only statistical model to predict 30-day readmission for hospitalized Medicaid patients with diabetes.

Australia’s adoption of electric vehicles has been maddeningly slow, but we’re well placed to catch up fast

Retrieved on: 
Friday, April 21, 2023
Workforce, Adoption, Mineral, Travel, Industry, EV, Cooperative Research Centre, Electricity, History, Government, Wind, SEVI, Tritium, Nickel, ARENA, ACE, Strategy, Frustration, RACE, NASDAQ, Copper, Tesla, Health, Cobalt, Air pollution, Gasoline, Renewable energy, Rail transport, Television, Video game

Roll forward 122 years and there’s now a registered motor vehicle for every one of the 20 million people of driving age in Australia.

Key Points: 
  • Roll forward 122 years and there’s now a registered motor vehicle for every one of the 20 million people of driving age in Australia.
  • The slow pace at which Australia has adopted electric vehicles is maddening to many.
  • But the transition to electric vehicles is changing gear in Australia, driven by both consumers and government.
  • All the states and territories and many local governments had for some time taken steps to boost the uptake of electric vehicles.

A country wedded to the car

    • You can see why cars are so popular in a country like Australia.
    • We’re the sixth-largest country in the world, but the 55th-most-populous.
    • With only around three people per square kilometre, we regularly travel large distances through sparsely populated areas.
    • Australia also had a burgeoning automotive industry, which spawned fierce loyalties among fans of domestic brands.

We have the resources to go electric

    • Adding to the frustration of EV advocates is Australia’s wealth of resources that can enhance the benefits electric vehicles offer.
    • Australia has some of the best wind energy resources in the world with an estimated 5 terawatts of potential.

And there’s expertise to accelerate the transition


    While the new national strategy makes all the right noises, the main critique emerging is that it lacks real teeth. In particular, the specifics of a badly needed fuel-efficiency standard are still being developed. However, there is still plenty in the strategy to offer promise. It identifies the need for:
    • Australia’s world-class energy researchers have been exploring issues relating to a mostly renewables-powered electricity grid for decades.
    • In recent years, they have been investigating how electric vehicles could become an important asset for the electricity grid as “batteries on wheels”.
    • The renewable energy agency, ARENA, has spent over $2 billion to increase the renewable energy supply in Australia.
    • It has received $69 million in government funding and $280 million in cash and in-kind support from partners to accelerate the transition to reliable, affordable, clean energy.

Curative Biotechnology Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop Study

Retrieved on: 
Thursday, January 5, 2023
Clinical trial, Metformin, National Eye Institute, CRADA, Cooperative Research Centre, Michaels, Development, AMD, Degenerative disease, OTC, FDA, IND, GA, Cooperative research and development agreement, Pharmaceutical industry, Rabbit

Boca Raton, FL, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel treatments for rare diseases and conditions, announced today that it has successfully completed its Investigational New Drug (IND) enabling Tolerance and Toxicology Study of Metformin HCL Solution by Topical Instillation (eye drops) in Rabbits.

Key Points: 
  • Boca Raton, FL, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel treatments for rare diseases and conditions, announced today that it has successfully completed its Investigational New Drug (IND) enabling Tolerance and Toxicology Study of Metformin HCL Solution by Topical Instillation (eye drops) in Rabbits.
  • Paul Michaels, Chairman and President of Curative Biotechnology, said, “We are pleased to announce the successful completion of these important studies, outlined in our Pre IND meeting with the FDA.
  • We are now able to move on to preparing the Company’s first IND application to move our Metformin reformulation into a clinical trial to treat Intermediate Dry Age-Related Macular Degeneration (AMD) and Geographical Atrophy (GA) resulting from AMD.”
    Michaels continued, “Both Dry AMD and GA are currently unmet medical needs with no FDA approved efficacious treatment options.
  • As previously announced , we will be conducting the first in human study under a CRADA (Cooperative Research and Development Agreement) with the National Eye Institute of the National Institutes of Health, in Bethesda Maryland.”

First Nations Engagement is Vital to Indigenous Businesses and a Successful Mining Supply Chain

Retrieved on: 
Thursday, November 3, 2022
Missing and murdered Indigenous women, First Nations, Compliance, International Convention Centre Sydney, Coal companies of Australia, Contract, Woman, Conference, CRC, CEO, Decision-making, Australasian Institute of Mining and Metallurgy, Cooperative Research Centre, Mine, Aborigine, Coal, Metallurgy, Human, Economic development, Policy, Titan Mare Explorer, 2018 Victorian state election, Learning, International Mines Rescue Competition, Whaling, Mining, NSW

Setting the tone for the focus on this inclusion, Florence Drummond, the CEO of Indigenous Women in Mining and Resources Australia (IWIMRA) delivered a powerful First Nations Partner address.

Key Points: 
  • Setting the tone for the focus on this inclusion, Florence Drummond, the CEO of Indigenous Women in Mining and Resources Australia (IWIMRA) delivered a powerful First Nations Partner address.
  • IWIMRA has partnered with IMARC, working to raise the profile of First Nations women and contributing to best practice solutions ensuring the visibility, voice and quality participation of Indigenous women within the sector.
  • Ms. Drummond also chaired a panel of influential industry leaders at IMARC, discussing the importance of Indigenous participation across the supply chain with a focus on the engagement and procurement of Indigenous businesses.
  • She says in the last three years engagement of Indigenous businesses has improved, but there are still a lot of obstacles.

IMARC to Put the Spotlight on Indigenous Participation in Mining

Retrieved on: 
Friday, October 14, 2022
2018 Victorian state election, Life, Conference, Woman, Australasian Institute of Mining and Metallurgy, Employment, Policy, Cooperative Research Centre, Mine, Corporation, Workforce, International Convention Centre Sydney, CRC, Titan Mare Explorer, History, Missing and murdered Indigenous women, Partnership, Human, Aborigine, Coal companies of Australia, Learning, Industry, CEO, Rehabilitation, Rights, First Nations, Government, Metallurgy, Wenco International Mining Systems, UN Declaration on the Elimination of All Forms of Intolerance and of Discrimination Based on Religion or Belief, Indigenous peoples, Texas Department of Housing and Community Affairs, Mining, Whaling, Mining

Several influential leaders will discuss the importance of Indigenous participation across the supply chain including Florence Drummond, the CEO of Indigenous Women in Mining and Resources Australia (IWIMRA).

Key Points: 
  • Several influential leaders will discuss the importance of Indigenous participation across the supply chain including Florence Drummond, the CEO of Indigenous Women in Mining and Resources Australia (IWIMRA).
  • The organisation has partnered with IMARC, working to raise the profile of First Nations women and contributing to best practice solutions ensuring the visibility, voice and quality participation of Indigenous women within the sector.
  • The International Mining and Resources Conference (IMARC ) is where global mining leaders collaborate on trends in mining, investment and innovation towards a sustainable future.
  • IMARC is developed in collaboration with its founding partners the Victorian State Government of Australia, Austmine, the Australasian Institute of Mining and Metallurgy (AusIMM) and Mines and Money.

Xosomix Awarded NIH Phase I SBIR Grant to Develop Diagnostic Biomarker for Endometriosis

Retrieved on: 
Tuesday, October 4, 2022
UC, Solution, Seminal vesicles, CSO, Pelvic pain, Alzheimer's disease, Technology, Endometriosis, NICHD, MD, Synthetic control method, Multimedia, NIH, Infertility, Eunice Kennedy Shriver National Institute of Child Health and Human Development, FDA, SBIR, Exosome, Cooperative Research Centre, Human development, Cell, Communication, CRADA, SAN, Development, Biomarker, Diagnosis, Center, Woman, Lists of diseases, UC San Diego Health, Pharmaceutical industry, Medical imaging, Rett syndrome

This grant will enable Xosomix to develop an early diagnostic biomarker for endometriosis.

Key Points: 
  • This grant will enable Xosomix to develop an early diagnostic biomarker for endometriosis.
  • Xosomix receives SBIR from NICHD to develop non-invasive biomarker that avoids surgery, the only FDA approved diagnosis
    Approximately 10% of reproductive age women, more than 4 million in United States alone, are affected by endometriosis.
  • This is an underestimate as invasive surgery is the only FDA approved diagnosis of endometriosis.
  • Xosomix has a proprietary platform technology that can tap into all the signals in exosomes on an individual basis at discovery phase.

Argonne National Laboratory and Constellation Sign Long-Term Agreement to Develop Carbon-Free Power Generation Technologies

Retrieved on: 
Thursday, September 22, 2022
Other Policy Issues, Other Science, Technology, Research, Public Policy, Government, Nuclear, Climate Change, Environment, Other Energy, Utilities, Green Technology, Alternative Energy, Energy, Other Technology, White House, Federal Government, State, Local, Environmental Policy, Science, Public Policy, Environmental Issues, Carbon, Constellation, Weather, Development, Electrolysis, Strategic management, U.S. Department of Defense Strategy for Operating in Cyberspace, Public sector, Argonne National Laboratory, United, Cooperative Research Centre, Industry, Climate change, Hydrogen, Wind, Transport, Electric grid security, Agreement, Research, DOE, Argonne, Renewable energy

Carbon-free energy sources, such as wind, solar and nuclear power, are being pursued to reduce carbon emissions and improve the resiliency of power generation under extreme weather events caused by a warming planet.

Key Points: 
  • Carbon-free energy sources, such as wind, solar and nuclear power, are being pursued to reduce carbon emissions and improve the resiliency of power generation under extreme weather events caused by a warming planet.
  • In September 2022, the U.S. Department of Energys (DOE) Argonne National Laboratory has launched a long-term agreement with Constellation to evaluate trends in the countrys energy system and develop technologies for more efficient, carbon-free power generation.
  • The Cooperative Research and Development Agreement (Agreement) between Constellation and Argonne will support various projects through October 2028.
  • This Agreement can help align our research and development at the laboratory, because it gives us much better insight into what industry actually needs.

Gainwell’s Cutting-Edge Research Platform Enables Stanford’s Breakthrough Study on Opioid Addiction

Retrieved on: 
Wednesday, August 31, 2022
University, Medicaid, Technology, Digital technology, Pain, Research, Government, Death, Solution, Opioid, Heart, Kenneth Gainwell, Stanford University School of Medicine, Prescription, Organization, Opioid use disorder, GLOBE, Cooperative Research Centre, Stanford University, Digital health, Industry, Health, CDC, Patient, Pharmaceutical industry, Public relations, Management

Gainwells advanced research platform and access to de-identified Medicaid claims, provided by its clients, give the company a one-of-a-kind data asset.

Key Points: 
  • Gainwells advanced research platform and access to de-identified Medicaid claims, provided by its clients, give the company a one-of-a-kind data asset.
  • A new Stanford University study published in the PLOS Digital Health journal showed a patients first experience with an opioid prescription is a major factor driving opioid addiction.
  • Gainwell facilitated the research data environment for Stanford under the umbrella of Australias Digital Health CRC (Cooperative Research Centre) to sponsor this research.
  • Annette Schmiede, Digital Health Cooperative Research Centre CEO, said, Stanfords research and Gainwells leadership show the global impact our work is having on solving seemingly intractable healthcare issues.

Portage Biotech Announces Results for Fiscal Year Ended March 31, 2022

Retrieved on: 
Monday, August 1, 2022
Linda, Stanford University, Fiscal, Cancer, Melanoma, Cooperative research and development agreement, Cooperative Research Centre, News, Immunotherapy, Company, LinkedIn, LLC, Adenosine, Acquisition, ASCO, IPhone XR, Large-cell lung carcinoma, Research, American Society of Clinical Oncology, Income, University of Birmingham, EVP, Infection, PRTG, D, D&O, Aptamer, Society, National, Nanoparticle, GLOBE, VLP, Industry, Twitter, RAGE, National Cancer Institute, Nature, Quality of life, Achievement, Public relations, Survival, Research and development, NCI, University, CRADA, Development, Evaluation, Hand, Therapy, AACR, NASDAQ, Liposome, Stimulator of interferon genes, B cell, Patient, Nucleic acid metabolism, NK, Animal, Vaccine, Pharmaceutical industry, Life insurance, Management

WESTPORT, Conn., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company developing therapies to improve patient lives and increase survival by avoiding and overcoming cancer treatment resistance, today announced financial results for the fiscal year ended March 31, 2022.

Key Points: 
  • Payments of up to $32M in Portage ordinary shares or cash may be triggered upon achievement of future development and sales milestones.
  • Operating expenses included $9.1 million of non-cash share-based compensation expense in Fiscal 2022, compared to $8.8 million in Fiscal 2021.
  • Research & development ("R&D") costs decreased by approximately $0.5 million, or approximately 7%, from approximately $7.3 million in Fiscal 2021, to approximately $6.8 million in Fiscal 2022.
  • General and administrative ("G&A") expenses increased by approximately $3.7 million, or approximately 73%, from approximately $5.1 million in Fiscal 2021, to approximately $8.8 million in Fiscal 2022.

Novelis signs Cooperation Research Agreement with Airbus

Retrieved on: 
Thursday, July 21, 2022
Copper, Industry, U.S. Securities and Exchange Commission, Metal, Aluminium, Aditya Birla Group, Recycling, Risk, Partnership, Solution, Cooperative Research Centre, Uncertainty, Nature, News, Novelis, Senior, Security (finance), Form 10-K, Airbus

Building on today's strong partnership between Novelis and Airbus, this agreement will accelerate the pace of the companies' joint R&D programs.

Key Points: 
  • Building on today's strong partnership between Novelis and Airbus, this agreement will accelerate the pace of the companies' joint R&D programs.
  • As a strategic supplier of aluminum plate and sheet to Airbus, Novelis is aiding the evolution of aircraft design, material, and manufacturing, with a focus on sustainability.
  • "At Novelis, we are confident that this agreement will allow us to take full advantage of the circularity potential of aluminum as a material that can be infinitely recycled without loss of performance," said Philippe Meyer, Senior Vice President and Chief Technology Officer at Novelis.
  • Statements made in this news release that describe Novelis' intentions, expectations or predictions may be forward-looking statements within the meaning of securities laws.